Plasmid-borne blaSHV genes in klebsiella pneumoniae are associated with strong promoters

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 5, 2009, Pages

  Turner, Mark S ^a,b   Andersson, Patiyan ^c   Bell, Jan M ^d,e   Turnidge, John D ^d,e   Harris, Tegan ^a,c   Giffard, Philip M ^a,c  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^d WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^e UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

ESBLs; Expression; High resolution melting; K. Pneumoniae; SHV

Indexed keywords

BETA LACTAMASE SHV; EXTENDED SPECTRUM BETA LACTAMASE; BETA LACTAMASE;

ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENETICS; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE EXPRESSION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; KLEBSIELLA PNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLASMID; PROMOTER REGION; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; MICROBIOLOGY; MOLECULAR GENETICS; TRANSPOSON;

BETA-LACTAMASES; DNA TRANSPOSABLE ELEMENTS; GENE EXPRESSION PROFILING; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MOLECULAR SEQUENCE DATA; PLASMIDS; PROMOTER REGIONS, GENETIC;

EID: 73949142622     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp338     Document Type: Article

References (10)

1. Chaves J, Ladona MG, Segura C et al. SHV-1 β-lactamase is mainly a chromosomally encoded species-specific enzyme in Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45: 2856-61.
2. Ford PJ, Avison MB. Evolutionary mapping of the SHV b-lactamase and evidence for two separate IS26-dependent blaSHV mobilization events from the Klebsiella pneumoniae chromosome. J Antimicrob Chemother 2004; 54: 69-75.
3. SHV gene. Antimicrob Agents Chemother 2008; 52: 441-5.
4. Podbielski A, Schonling J, Melzer B et al. Different promoters of SHV-2 and SHV-2a b-lactamase lead to diverse levels of cefotaxime resistance in their bacterial producers. J Gen Microbiol 1991; 137: 1667-75.
5. Rice LB, Carias LL, Hujer AM et al. High-level expression of chromosomally encoded SHV-1 β-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin- tazobactam in a clinical isolate of Klebsiella pneumoniae. Antimicrob Agents Chemother 2000; 44: 362-7.
6. Hirakata Y, Matsuda J, Miyazaki Y et al. Regional variation in the prevalence of extended-spectrum b-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn Microbiol Infect Dis 2005; 52: 323-9.
7. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement M100-S18. CLSI, Wayne, PA, USA, 2008.
8. SHV-5. Antimicrob Agents Chemother 2007; 51: 1164-71.
9. Welch TJ, Fricke WF, McDermott PF et al. Multiple antimicrobial resistance in plague: an emerging public health risk. PLoS ONE 2007; 2: e309.
10. Chen YT, Liao TL, Liu YM et al. Mobilization of qnrB2 and ISCR1 in plasmids. Antimicrob Agents Chemother 2009; 53: 1235 7.